Robert Elfont

Dr. Elfont is a neurologist with nearly two decades of experience in the pharmaceutical sector. Most recently, he served as Head of Clinical Development and Pharmacovigilance at Adamas. He has served as CMO for several biotech companies including PhotoThera and Avigen. Before moving to the biotech sector, Dr. Elfont held senior medical director positions at Roche, Pfizer and Teva Neuroscience.

Elfont was previously an assistant professor of neurology at Johns Hopkins University School of Medicine and Drexel University College of Medicine, where his research activities focused on immune cell trafficking.